In a patient with stage 4 chronic kidney disease who is volume‑depleted (prerenal azotemia) and experiences presyncopal episodes, which of the following nighttime medications should be avoided: lamotrigine, bupropion, aripiprazole, duloxetine, atorvastatin, methenamine, oxybutynin, torsemide, gabapentin, calcitriol, midodrine, Zepboumd (tirzepatide), sodium bicarbonate, aspirin, vitamin C?

Medications to Avoid at Night in Stage 4 CKD with Volume Depletion and Presyncope

In this patient with stage 4 CKD, volume depletion (prerenal azotemia), and presyncopal episodes, you should avoid torsemide and midodrine at night.

Critical Nighttime Medications to Avoid

Torsemide (Loop Diuretic)

Torsemide must be avoided at nighttime dosing in this clinical scenario for multiple reasons:

• Worsening Volume Depletion: The patient already has prerenal azotemia from volume depletion. Loop diuretics cause "potentially symptomatic dehydration, blood volume reduction and hypotension and worsening renal function, including acute renal failure particularly in salt-depleted patients" 1. Nighttime dosing would exacerbate the existing volume-depleted state during sleep when oral intake is impossible.

• Hypotension Risk: Torsemide causes hypotension 1, which directly increases fall and syncope risk in a patient already experiencing presyncope. The 2013 ACC/AHA heart failure guidelines emphasize that "inappropriately high doses of diuretics will lead to volume contraction, which can increase the risk of hypotension and renal insufficiency" 2.

• Guideline-Based Timing: The K/DOQI guidelines specifically recommend "modification of dosing regimens so that cardiovascular medications do not adversely impact the delivery of dialysis and ultrafiltration. Nocturnal dosing of medications should be considered" 3—but this refers to avoiding diuretics at night to prevent hypotension during sleep.

Midodrine (Alpha-Agonist)

Midodrine should specifically be avoided at nighttime due to:

• Supine Hypertension: The FDA label explicitly warns that "patients should be told to avoid taking their dose if they are to be supine for any length of time, i.e., they should take their last daily dose of midodrine 3 to 4 hours before bedtime to minimize nighttime supine hypertension" 4.

• Renal Impairment Concerns: In stage 4 CKD, "midodrine should be used with caution in patients with renal impairment, with a starting dose of 2.5 mg" because "desglymidodrine is eliminated via the kidneys, and higher blood levels would be expected in such patients" 4.

• Paradoxical Effect: While midodrine treats orthostatic hypotension during the day, nighttime dosing causes dangerous supine hypertension when the patient is lying down for extended periods.

Medications Requiring Caution but Not Absolute Avoidance

Gabapentin

• Requires dose reduction in stage 4 CKD 5 but can be given at night if appropriately dosed
• "Both medications also require dosage reduction in patients with renal insufficiency" 5
• The 2024 KDIGO guidelines emphasize monitoring for medications with "narrow therapeutic windows" in CKD 6

Oxybutynin

• Anticholinergic effects may worsen orthostatic hypotension
• Can cause urinary retention, which midodrine already predisposes to 4
• Consider avoiding or using with extreme caution given the presyncope history

Duloxetine

• Generally safe in CKD but can cause orthostatic hypotension
• Monitor blood pressure closely in this volume-depleted patient

Medications Generally Safe at Night

The following medications do not require nighttime avoidance in this patient:

• Lamotrigine: Requires dose adjustment in severe renal impairment 7 but timing is not critical
• Bupropion: Hepatically metabolized, no specific nighttime concerns
• Aripiprazole: No renal dose adjustment needed
• Atorvastatin: Safe in CKD, no timing restrictions 3
• Methenamine: Requires adequate urine output but no nighttime restriction
• Calcitriol: Monitor calcium-phosphate product (Ca × P < 70 mg²/dL²) 8 but timing flexible
• Zepbound (tirzepatide): GLP-1 agonist, safe in CKD 9, 10
• Sodium bicarbonate: May help metabolic acidosis in CKD
• Aspirin: Recommended in CKD for cardiovascular protection 3
• Vitamin C: Use cautiously in CKD but no nighttime restriction

Key Clinical Pitfalls

1. Never give loop diuretics at night in volume-depleted patients—this creates a perfect storm for nocturnal hypotension, falls, and acute kidney injury
2. Midodrine's last dose must be 3-4 hours before bed per FDA labeling to prevent supine hypertension
3. Monitor renal function closely when using any medication in stage 4 CKD, as the 2024 KDIGO guidelines emphasize that "people with CKD may be more susceptible to the nephrotoxic effects of medications" 6, 11
4. Address the volume depletion first before optimizing other medications—the prerenal azotemia needs correction to prevent progression to acute tubular necrosis